Rentschler Biopharma

Laupheim, Germany
Find alternatives to Rentschler Biopharma for Monoclonal Antibody →
Monoclonal Antibody Recombinant Protein
Program data pending ClinicalTrials.gov matching · Last scored 2026-10-29
77.8
Signal Score
✓ FDA Inspections (2) ○ Clinical Trials ○ SEC Filings ✓ Press (4) ✓ EMA GMP (2) ○ MHRA GMP ✓ HC GMP (8)

Quick Facts: Rentschler Biopharma

Signal Score
77.8/100 (as of 2026-10-29)
Quality Compliance
99.2/100
Headquarters
Laupheim, Germany
Website
Modalities
Monoclonal Antibody, Recombinant Protein
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Rentschler Biopharma

Pure-play CDMO.

Signal Score & Pillar Breakdown

Quality Compliance 99.2
FDA Inspections2 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2025-01-17)
EMA GMP Certificates2 on record
Most Recent HC OutcomeCompliant · 2023-05-05
HC Attribution8 company-level
Source: Health Canada Drug and Health Product Inspections Database. Ratings shown in Health Canada's own vocabulary; not equivalent to FDA classifications. Company-level records are attributed by the regulator's published establishment name, not by a verified site identifier. Contains information licensed under the Open Government Licence – Canada.
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesMonoclonal Antibody, Recombinant Protein
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 58.0
1 manufacturing site: Laupheim, DE
Modalities: Monoclonal Antibody, Recombinant Protein
Capacity assessment: 58.0/100
Sites: Laupheim, DE
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
Press Signals4 articles (not scored)
1 manufacturing site: Laupheim, DE
Modalities: Monoclonal Antibody, Recombinant Protein
Capacity assessment: 58.0/100

Rentschler Biopharma FDA Inspection History

2025-01
2023-05
NAI VAI OAI
Date Site Type 483 citations posted Classification
2025-01-17
Rentschler Biopharma Inc.
Milford, Massachusetts Facility-linked
Drug Quality Assurance Not posted Voluntary Action Indicated (VAI)
2023-05-05
Rentschler Biopharma SE
Laupheim Company-level
Drug Quality Assurance Not posted Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Nov 21, 2026

Rentschler Biopharma EMA GMP Compliance 2 certificates

2026-02
2023-05
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
DE_BW_01_GMP_2026_0092 Rentschler Biopharma SE Germany 2026-02-05 COMPLIANT
DE_BW_01_GMP_2025_0209 Rentschler Biopharma SE Germany 2023-05-05 COMPLIANT
Source: EMA EudraGMDP · Retrieved Nov 21, 2026

Japan-accredited overseas site (PMDA)

sterile, biologics · 2 sites

  • Laupheim, Germany · Rentschler Biopharma SE — sterile, biologics · valid to May 30, 2028
  • Milford, United States · Rentschler Biopharma Inc. — biologics · valid to Oct 5, 2031
Previously accredited (cancelled) · 1
  • Laupheim, Germany · Rentschler Biopharma SE — sterile, biologics · cancelled Oct 1, 2017

No longer on PMDA's current list. Shown for history only; not used in search tags.

PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)

Hiring Activity 38 open roles Beta

From public job postings on Rentschler Biopharma's careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
38
open roles
21
in manufacturing, quality, PD/MSAT, engineering or regulatory (55%)
Trend from Nov 25, 2026
Tracking started Oct 26, 2026. 30-day change shows after 30 days, 90-day after Jan 24, 2027.
Since Nov 19, 2026: 2 new postings, 2 taken down.
What this may mean
  • 6 of the 13 openings at Milford MA United States are in quality (QA/QC). That fits added testing or batch-release work, but it can also be normal turnover.
By function
Manufacturing & operations 9
Quality (QA / QC) 9
Process development & MSAT 1
Engineering & facilities 2
Commercial, BD & client projects 1
Other (finance, HR, IT, other) 16
By site
Laupheim Germany profile site
6 mfg/ops · 3 QA/QC · 2 eng. · 14 other
25
Milford MA United States profile site
3 mfg/ops · 6 QA/QC · 1 PD/MSAT · 3 other
13
Modality words in job titles
Biologics (cell culture, USP/DSP)1
Notable roles
Director, Quality Control Technical Services Senior operations / quality role · Milford MA United States
Director, Quality Control, Analytics Senior operations / quality role · Milford MA United States
Senior Director Quality Assurance, QP Senior operations / quality role · Laupheim Germany
Latest postings
Recruiter Other (finance, HR, IT, other) · Laupheim Germany
Quality Control Data Reviewer Quality (QA / QC) · Milford MA United States
Werkstudent, Support Splkche Other (finance, HR, IT, other) · Laupheim Germany
Pharmazeutischer Operator, DSP, 1 Jahresvertrag Manufacturing & operations · Laupheim Germany
Production Planner Scheduler Manufacturing & operations · Milford MA United States
MES Implementation Project Manager Commercial, BD & client projects · Milford MA United States
Pharmazeutischer Operator, Produktion Support, 1 Jahresvertrag Manufacturing & operations · Laupheim Germany
Director, Quality Control Technical Services Quality (QA / QC) · Milford MA United States
Werkstudent, Technik und Standortentwicklung Other (finance, HR, IT, other) · Laupheim Germany
Manufacturing Associate II, Buffer Media Services, 3 6 Month Contract Manufacturing & operations · Milford MA United States
Sachbearbeiter, QA Systeme, 2 Jahresvertrag Quality (QA / QC) · Laupheim Germany
Process Manager, DSP Other (finance, HR, IT, other) · Laupheim Germany
Coverage: counted from Rentschler Biopharma's own careers board. Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source: rentschler.wd3.myworkdayjobs.com · Checked Nov 20, 2026 · Tracking since Oct 26, 2026

Company Signals 4 articles

Company announcements, not verified evidence. They do not change any score.
facility_expansion 2026-03-25
Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion - Manufacturing Digital Magazine
Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion  Manufacturing Digital Magazine
facility_expansion 2026-03-24
Rentschler Biopharma Advances Milford Site Expansion - Contract Pharma
Rentschler Biopharma Advances Milford Site Expansion  Contract Pharma
facility_expansion 2026-03-24
Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion - GlobeNewswire
Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion  GlobeNewswire
facility_expansion 2026-03-24
Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion - GlobeNewswire
Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion  GlobeNewswire

Frequently Asked Questions About Rentschler Biopharma

How many FDA inspections does Rentschler Biopharma have on record?
CDMO Signal tracks 2 FDA inspections for Rentschler Biopharma, sourced from the FDA inspection database. See the full inspection history above.
Has Rentschler Biopharma received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Rentschler Biopharma.
Does Rentschler Biopharma hold EMA or MHRA GMP certificates?
CDMO Signal tracks 2 EMA GMP certificates for Rentschler Biopharma.
What is Rentschler Biopharma's CDMO Signal Score?
Rentschler Biopharma has a Signal Score of 78/100, based on quality, operations, financial stability, and capacity data.
Evaluating Rentschler Biopharma for a manufacturing program?
Use the free AI matchmaker to compare Rentschler Biopharma against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Recombinant Protein CDMOs →

Similar CDMOs

KBI Biopharma
Durham, NC · Boulder, CO
Signal Score: 84.1
Monoclonal Antibody, Recombinant Protein, AAV (analytical only), Plasmid DNA
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 79.9
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation
Catalent
Tampa, FL
Signal Score: 76.1
Monoclonal Antibody, Recombinant Protein, ADC, AAV, mRNA, Plasmid DNA, Fill-Finish
Lonza
Basel, Switzerland
Signal Score: 72.8
AAV, Lentiviral, Cell Therapy, mRNA, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation, Small Molecule API, High-Potency APIs, Oral Solid Dose
Samsung Biologics
Incheon, South Korea, Rockville, Maryland, USA
Signal Score: 61.5
Monoclonal Antibody, Recombinant Protein, ADC, mRNA, Bispecific Antibody, Antibody Conjugate

Compare Rentschler Biopharma with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Rentschler Biopharma
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.